Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials

Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials

Abstract Background The benefits and risks of anti-acid medication in patients with idiopathic pulmonary fibrosis (IPF) remain a topic of debate. We investigated whether use of anti-acid medication at baseline was associated with differences in the natural course of disease or influenced the treatme...

Full description

Bibliographic Details
Main Authors: Ulrich Costabel, Jürgen Behr, Bruno Crestani, Wibke Stansen, Rozsa Schlenker-Herceg, Susanne Stowasser, Ganesh Raghu
Format: Article
Language:English
Published: BMC 2018-09-01
Series:Respiratory Research
Online Access:http://link.springer.com/article/10.1186/s12931-018-0866-0

Internet

http://link.springer.com/article/10.1186/s12931-018-0866-0

Similar Items